Have we cut ourselves too short in mapping CTL epitopes?

Trends in Immunology

Volumn 27, Issue 1, 2006, Pages 11-16

  Burrows, Scott R ^a   Rossjohn, Jamie ^b   McCluskey, James ^c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPSTEIN BARR VIRUS ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ALLELE; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN; IMMUNOGENICITY; PROTEIN BINDING; REVIEW;

EID: 30544452130     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.11.001     Document Type: Article

References (70)

1. K. Falk Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules Nature 351 1991 290 296
2. A. Stryhn Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding Eur. J. Immunol. 26 1996 1911 1918
3. M. DiBrino Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides Proc. Natl. Acad. Sci. U. S. A. 90 1993 1508 1512
4. D.F. Hunt Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry Science 255 1992 1261 1263
5. H. Rammensee SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50 1999 213 219
6. A.K. Nussbaum Using the World Wide Web for predicting CTL epitopes Curr. Opin. Immunol. 15 2003 69 74
7. G.E. Meister Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences Vaccine 13 1995 581 591
8. V. Apostolopoulos Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design Front. Biosci. 6 2001 D1311 D1320
9. L.C. Eisenlohr Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes J. Exp. Med. 175 1992 481 487
10. D.H. Fremont Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb Science 257 1992 919 927
11. E. Pamer, and P. Cresswell Mechanisms of MHC class I-restricted antigen processing Annu. Rev. Immunol. 16 1998 323 358
12. T. Wenzel Existence of a molecular ruler in proteasomes suggested by analysis of degradation products FEBS Lett. 349 1994 205 209
13. F. Momburg Peptide size selection by the major histocompatibility complex-encoded peptide transporter J. Exp. Med. 179 1994 1613 1623
14. J. Longmate Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes Immunogenetics 52 2001 165 173
15. F.E. Tynan High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance J. Biol. Chem. 280 2005 23900 23909
16. R.G. Urban A subset of HLA-B27 molecules contains peptides much longer than nonamers Proc. Natl. Acad. Sci. U. S. A. 91 1994 1534 1538
17. H.C. Guo Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle Nature 360 1992 364 366
18. J.A. Speir Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa Immunity 14 2001 81 92
19. M. Probst-Kepper An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes J. Exp. Med. 193 2001 1189 1198
20. Y. Chen Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations J. Immunol. 152 1994 2874 2881
21. M. Probst-Kepper Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501 J. Immunol. 173 2004 5610 5616
22. K.J. Green Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length Eur. J. Immunol. 34 2004 2510 2519
23. Y. Kawakami Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes J. Immunol. 166 2001 2871 2877
24. M. Theobald Targeting p53 as a general tumor antigen Proc. Natl. Acad. Sci. U. S. A. 92 1995 11993 11997
25. H. Benlalam Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes J. Immunol. 171 2003 6283 6289
26. J.J. Miles CTL recognition of a bulged viral peptide involves biased TCR selection J. Immunol. 175 2005 3826 3834
27. M.B. Oldstone Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes J. Exp. Med. 168 1988 559 570
28. R. Schirmbeck Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo J. Immunol. 152 1994 1110 1119
29. H. Hebart Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation Blood 99 2002 3830 3837
30. Y. Kawakami Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles J. Immunol. 161 1998 6985 6992
31. C.A. Aarnoudse Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1 Int. J. Cancer 82 1999 442 448
32. K. Takahashi Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein Proc. Natl. Acad. Sci. U. S. A. 88 1991 10277 10281
33. N.V. Sipsas Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1 J. Clin. Invest. 99 1997 752 762
34. M.D. Nastke Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire Cell. Mol. Life Sci. 62 2005 77 86
35. W. Wang Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein Science 269 1995 1588 1590
36. M.P. Weekes The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo J. Virol. 73 1999 2099 2108
37. A.B. Rickinson, and D.J. Moss Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection Annu. Rev. Immunol. 15 1997 405 431
38. R. Chiari Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene Cancer Res. 59 1999 5785 5792
39. M. Schirle Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach Eur. J. Immunol. 30 2000 2216 2225
40. A.W. Purcell Quantitative and qualitative influences of tapasin on the class I peptide repertoire J. Immunol. 166 2001 1016 1027
41. H.D. Hickman Cutting edge: class I presentation of host peptides following HIV infection J. Immunol. 171 2003 22 26
42. H.D. Hickman Toward a definition of self: proteomic evaluation of the class I peptide repertoire J. Immunol. 172 2004 2944 2952
43. G.B. Stewart-Jones Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression J. Immunol. 175 2005 2459 2468
44. Tynan, F.E. et al. (2005) T cell receptor recognition of a super-bulged major histocompatibility complex class I-bound peptide. Nat. Immunol. 6, 1114-1112
45. A. Glithero Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity Immunity 10 1999 63 74
46. T. Crough Contemporaneous fluctuations in T cell responses to persistent herpes virus infections Eur. J. Immunol. 35 2005 139 149
47. V.A. Pudney CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells J. Exp. Med. 201 2005 349 360
48. M. Theobald Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes J. Exp. Med. 185 1997 833 841
49. N. Blake Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing Immunity 7 1997 791 802
50. G. Missale HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis J. Exp. Med. 177 1993 751 762
51. W. Chen Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues J. Exp. Med. 180 1994 1471 1483
52. M.J. Androlewicz, and P. Cresswell How selective is the transporter associated with antigen processing? Immunity 5 1996 1 5
53. T. Serwold ER aminopeptidases generate a unique pool of peptides for MHC class I molecules Nat. Immunol. 2 2001 644 651
54. M.G. Rudolph, and I.A. Wilson The specificity of TCR/pMHC interaction Curr. Opin. Immunol. 14 2002 52 65
55. D.N. Garboczi Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 Nature 384 1996 134 141
56. Y.H. Ding Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids Immunity 8 1998 403 411
57. K.C. Garcia Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen Science 279 1998 1166 1172
58. J.B. Reiser CDR3 loop flexibility contributes to the degeneracy of TCR recognition Nat. Immunol. 4 2003 241 247
59. J.B. Reiser Crystal structure of a T cell receptor bound to an allogeneic MHC molecule Nat. Immunol. 1 2000 291 297
60. J.B. Reiser A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex Immunity 16 2002 345 354
61. J.G. Luz Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) interactions J. Exp. Med. 195 2002 1175 1186
62. L. Kjer-Nielsen A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity Immunity 18 2003 53 64
63. G.B. Stewart-Jones A structural basis for immunodominant human T cell receptor recognition Nat. Immunol. 4 2003 657 663
64. B.M. Baker Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors J. Exp. Med. 193 2001 551 562
65. T.K. Baxter Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition J. Biol. Chem. 279 2004 29175 29184
66. N.A. Borg The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition Nat. Immunol. 6 2005 171 180
67. B.C. Sim Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition? Immunol. Today 19 1998 276 282
68. M. Krogsgaard Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity Nature 434 2005 238 243
69. D.J. Irvine Direct observation of ligand recognition by T cells Nature 419 2002 845 849
70. M.A. Purbhoo T cell killing does not require the formation of a stable mature immunological synapse Nat. Immunol. 5 2004 524 530